Efficacy and Safety of Pancreatoscopy-Guided Laser Lithotripsy Versus Electrohydraulic Lithotripsy in Managing Pancreatic Duct Stone: A System Review and Meta-Analysis.

PancreasSep 12, 2026 (epub)
Clinical ResearchGastroenterology

Kaixuan Zhang, Zhongchen Fan, Haoyu Cheng et al.

✦ AI-curated · Sources linked

In 30 seconds

This meta-analysis compared the efficacy and safety of pancreatoscopy-guided laser lithotripsy (LL) and electrohydraulic lithotripsy (EHL) in treating refractory pancreatic duct stones in 326 patients. The study found no significant differences in technical success (78.9% for LL vs. 87.0% for EHL), clinical success (86.5% vs. 85.0%), or adverse event rates (8.8% vs. 10.0%).

Key findings

  • Technical success rates were 78.9% for LL and 87.0% for EHL (P = 0.433).
  • Clinical success rates were 86.5% for LL and 85.0% for EHL (P = 0.728).
  • Adverse event rates were 8.8% for LL and 10.0% for EHL (P = 0.726).
  • Substantial heterogeneity was observed for technical success.

Why it matters

Understanding the comparative efficacy and safety of LL and EHL is crucial for clinicians managing refractory pancreatic duct stones, as it informs treatment decisions based on available resources and operator expertise.

Source

Published in Pancreas. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Gastroenterology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.